ConductScience.org, home

Paper455885

Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.

Sotaniemi EA and 4 others. Clin Pharmacol Ther, 1979. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity. Papers, record 455885. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/455885

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
3.17
iCite
Revised in PubMed
2019-05-09
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sotaniemi EAE A
2Anttila MM
3Pelkonen ROR O
4Järvensivu PP
5Sundquist HH

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LiverMajor topic
PropranololMajor topic
SotalolMajor topic
Adult
Aged
Angina Pectoris
Antipyrine
Cytochrome P-450 Enzyme System
Female
Half-Life
Humans
Hypertension
Male
Middle Aged

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
24271521Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats.Pharm Res1986https://conductscience.org/library/papers/24271521PubMed
12844326Therapeutic drug monitoring of antiarrhythmic drugs.Clin Pharmacokinet2003https://conductscience.org/library/papers/12844326PubMed
7506652Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.Drugs1993https://conductscience.org/library/papers/7506652PubMed
7308271Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7308271PubMed
7106158Elimination of pindolol in liver disease.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7106158PubMed
7014827A standard approach to compiling clinical pharmacokinetic data.J Pharmacokinet Biopharm1981https://conductscience.org/library/papers/7014827PubMed
6714293The effect of liver cirrhosis on the pharmacokinetics of phenprocoumon.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6714293PubMed
6639842Induction of propranolol metabolism by rifampicin.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6639842PubMed
6342901Pharmacokinetic drug interactions with propranolol.Clin Pharmacokinet1983https://conductscience.org/library/papers/6342901PubMed
6146342Enzyme induction and beta-adrenergic receptor blocking drugs.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6146342PubMed
6146338Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6146338PubMed
6105079Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/6105079PubMed
3987778Relationship between lipid composition and drug metabolizing capacity of human liver.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3987778PubMed
3770017Liver drug metabolism and blood pressure response to a lipophilic and hydrophilic beta blocker.Eur J Drug Metab Pharmacokinet1986https://conductscience.org/library/papers/3770017PubMed
3315621Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.Drugs1987https://conductscience.org/library/papers/3315621PubMed
2865154Polymorphic metabolism of the beta-adrenoreceptor blocking drugs and its clinical relevance.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/2865154PubMed
2864639Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.Naunyn Schmiedebergs Arch Pharmacol1985https://conductscience.org/library/papers/2864639PubMed
2612519The effect of a single treatment with cigarette smoke on the blood levels and hemodynamic effects of propranolol in rats.Eur J Drug Metab Pharmacokinet1989https://conductscience.org/library/papers/2612519PubMed
2373132The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/2373132PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/455885

GET https://conductscience.org/api/papers/v1/455885/authors